Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Students bump shoulders with architects at STEAM Studio
Most children won’t have experience working in a professional environment until they land their first job or internship, Mandi Sonnenberg said. “Some kids may have popped into their mom or dad’s work and have gone to a professional space at least a couple times in their life,” Sonnenberg said. “But for kids in the urban…
Smart City Living Lab opens, targets growing pains of a swelling city
The much-anticipated “Kansas City Living Lab” — a platform for application development that taps the Kansas City Smart City initiative — is now welcoming new tech partners. Using smart city infrastructure, the Living Lab allows innovators to test and commercialize technologies that can solve problems in Kansas City. The project is led by Think Big…
JE Dunn spinout Site 1001 raises millions more from local investors
A Kansas City-based tech firm that’s created a smart buildings platform recently raised another significant batch of venture capital funding. Site 1001 — a technology spin out from Kansas City construction giant JE Dunn Construction — raised $6 million to boost its engineering, research and sales efforts. The round was led by JE Dunn Construction…
Pure Pitch Rally palms $20K to KC startups
Kansas City already has the right lineup for its own tech rally, Karen Fenaroli said. “We have the investors, we have the start-up talent,” Fenaroli, founder of Fenaroli & Associates and organizer of Pure Pitch Rally, said. A pitch competition next month attempts to connect the two, offering winning entrepreneurs an opportunity to nab $1,000…